Concepedia

Eric Kaldjian

EK

37

Publications

4K

Citations

24

H-Index

1988

Active since

Affiliations

University of Michigan(Current)

National Cancer Institute

Pfizer (United States)

ViaCyte (United States)

National Institutes of Health

Eric Kaldjian is an author at University of Michigan specializing in medicine, pathology, and cell biology.

Top concepts

Publications per year

1988–2022

37

Publications

37

Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic Cancer

John J. Rinehart, Alex A. Adjei, Patricia LoRusso et al. · Journal of Clinical Oncology · 2004 · 635 citations

Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study

Uma Shankavaram, William C. Reinhold, Satoshi Nishizuka et al. · Molecular Cancer Therapeutics · 2007 · 329 citations · Full text

A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery

Jae K. Lee, Dmytro M. Havaleshko, HyungJun Cho et al. · Proceedings of the National Academy of Sciences · 2007 · 325 citations · Full text

Upregulation of Poly (ADP-Ribose) Polymerase-1 (PARP1) in Triple-Negative Breast Cancer and Other Primary Human Tumor Types

Valeria Ossovskaya, Ingrid Chou Koo, Eric Kaldjian et al. · Genes & Cancer · 2010 · 277 citations · Full text

, , +12

MicroRNA expression profiles for the NCI-60 cancer cell panel

Paul E. Blower, Joseph S. Verducci, Shili Lin et al. · Molecular Cancer Therapeutics · 2007 · 248 citations · Full text

Rows per page

1–5 of 37